Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

NCT05550805 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT05550805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05550805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Completed
Start date
November 1, 2017
Completion date
March 1, 2022
Enrollment
5,822 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major adverse cardiovascular events in patients with coronary artery disease